Dr Livia Carvalho is an early career research fellow who joined the Lions Eye Institute in April 2016 under an ARC Discovery Early Career Research Award. She has a BSc in Biological Sciences from the University of Brasilia, and an MSc in Neuroscience and a PhD in Genetics, from University College London (UCL). Following the end of her PhD studies, she completed 7 years of postdoctoral research training on inherited visual degeneration and ocular gene therapy at UCL Institute of Ophthalmology (UK) and the Schepens Eye Research Institute, Harvard Medical School (USA). Since moving to LEI, she has established her own group and independent research platforms, the Retinal Genomics and Therapy Group. Her current research focus is on creating research platforms in the areas of gene therapy treatments for inherited retinal dystrophies, alongside understanding the cellular and molecular mechanisms behind retinal degeneration, photoreceptors cell death mechanisms, and retinal development during disease.